Prevalence of Eligibility Criteria for the Systolic Blood Pressure Intervention Trial in US Adults Among Excluded Groups: Age <50 Years, Diabetes, or a History of Stroke.

Bress, A; Tanner, R M; Hess, R; Gidding, S S; Colantonio, L D; Shimbo, D; Muntner, P

Bress, A; Tanner, R M; Hess, R; Gidding, S S; Colantonio, L D; Shimbo, D; Muntner, P.

Afiliación

Bress A; Pharmacotherapy, University of Utah, Salt Lake City, UT.
Tanner RM; Epidemiology, University of Alabama at Birmingham, Birmingham, AL.
Hess R; Population Health Sciences, University of Utah, Salt Lake City, UT.
Gidding SS; Nemours Cardiac Center, Alfred I. DuPont Hospital for Children, Salt Lake City, DE.
Colantonio LD; Epidemiology, University of Alabama at Birmingham, Birmingham, AL.
Shimbo D; Medicine, Columbia University, New York, NY.
Muntner P; Epidemiology, University of Alabama at Birmingham, Birmingham, AL.

J Am Soc Hypertens ; 10 Suppl 1: e6-e7, 2016 Jul.

Article en En | MEDLINE | ID: mdl-27677143

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prevalence_studies / Risk_factors_studies Idioma: En Revista: J Am Soc Hypertens Asunto de la revista: ANGIOLOGIA / CARDIOLOGIA Año: 2016 Tipo del documento: Article Pais de publicación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google